Timothy Daley
Stock Analyst at Wells Fargo
(3.25)
# 1,164
Out of 4,413 analysts
58
Total ratings
51.43%
Success rate
1.36%
Average return
Main Sectors:
21 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QGEN Qiagen | Initiates: Equal-Weight | $45 | $42.81 | +5.86% | 1 | Dec 19, 2023 | |
| MYGN Myriad Genetics | Initiates: Equal-Weight | $20 | $19.47 | +2.72% | 1 | Dec 19, 2023 | |
| RVTY Revvity | Initiates: Equal-Weight | $95 | $102.60 | -7.41% | 1 | Dec 19, 2023 | |
| BRKR Bruker | Initiates: Equal-Weight | $72 | $79.03 | -8.90% | 1 | Dec 19, 2023 | |
| A Agilent Technologies | Maintains: Overweight | $160 → $145 | $138.69 | +4.55% | 5 | Nov 22, 2023 | |
| MTD Mettler-Toledo International | Maintains: Overweight | $1,520 → $1,300 | $1,249.75 | +4.02% | 5 | Nov 13, 2023 | |
| WAT Waters | Maintains: Equal-Weight | $305 → $285 | $315.92 | -9.79% | 5 | Nov 8, 2023 | |
| DHR Danaher | Maintains: Overweight | $285 → $247 | $246.89 | +0.04% | 3 | Oct 3, 2023 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $280 → $275 | $232.69 | +18.18% | 4 | Sep 22, 2023 | |
| LH Laboratory Corporation of America Holdings | Maintains: Overweight | $290 → $270 | $201.32 | +34.11% | 3 | Aug 14, 2023 | |
| NEOG Neogen | Maintains: Overweight | $22 → $28 | $12.25 | +128.57% | 2 | Aug 14, 2023 | |
| STVN Stevanato Group | Maintains: Overweight | $30 → $35 | $28.23 | +23.98% | 6 | Jul 31, 2023 | |
| TMO Thermo Fisher | Maintains: Underweight | $505 → $520 | $574.99 | -9.56% | 3 | Jul 28, 2023 | |
| NOTV Inotiv | Initiates: Overweight | $9 | $3.92 | +129.59% | 1 | Jul 20, 2023 | |
| RGEN Repligen | Initiates: Overweight | $185 | $158.36 | +16.82% | 1 | Jul 20, 2023 | |
| HOLX Hologic | Maintains: Equal-Weight | $80 → $85 | $76.28 | +11.43% | 3 | May 2, 2023 | |
| IQV IQVIA Holdings | Maintains: Equal-Weight | $235 → $220 | $232.94 | -5.56% | 2 | May 1, 2023 | |
| ICLR ICON PLC | Maintains: Equal-Weight | $245 → $220 | $301.61 | -27.06% | 2 | May 1, 2023 | |
| AVTR Avantor | Maintains: Overweight | $25 → $28 | $24.42 | +14.66% | 4 | Feb 8, 2023 | |
| DGX Quest Diagnostics | Maintains: Equal-Weight | $135 → $140 | $137.55 | +1.78% | 2 | Feb 3, 2023 | |
| TECH Bio-Techne | Upgrades: Equal-Weight | $90 | $73.46 | +22.52% | 3 | Jan 10, 2023 |
Qiagen
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $45
Current: $42.81
Upside: +5.86%
Myriad Genetics
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $20
Current: $19.47
Upside: +2.72%
Revvity
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $95
Current: $102.60
Upside: -7.41%
Bruker
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $72
Current: $79.03
Upside: -8.90%
Agilent Technologies
Nov 22, 2023
Maintains: Overweight
Price Target: $160 → $145
Current: $138.69
Upside: +4.55%
Mettler-Toledo International
Nov 13, 2023
Maintains: Overweight
Price Target: $1,520 → $1,300
Current: $1,249.75
Upside: +4.02%
Waters
Nov 8, 2023
Maintains: Equal-Weight
Price Target: $305 → $285
Current: $315.92
Upside: -9.79%
Danaher
Oct 3, 2023
Maintains: Overweight
Price Target: $285 → $247
Current: $246.89
Upside: +0.04%
Charles River Laboratories International
Sep 22, 2023
Maintains: Overweight
Price Target: $280 → $275
Current: $232.69
Upside: +18.18%
Laboratory Corporation of America Holdings
Aug 14, 2023
Maintains: Overweight
Price Target: $290 → $270
Current: $201.32
Upside: +34.11%
Neogen
Aug 14, 2023
Maintains: Overweight
Price Target: $22 → $28
Current: $12.25
Upside: +128.57%
Stevanato Group
Jul 31, 2023
Maintains: Overweight
Price Target: $30 → $35
Current: $28.23
Upside: +23.98%
Thermo Fisher
Jul 28, 2023
Maintains: Underweight
Price Target: $505 → $520
Current: $574.99
Upside: -9.56%
Inotiv
Jul 20, 2023
Initiates: Overweight
Price Target: $9
Current: $3.92
Upside: +129.59%
Repligen
Jul 20, 2023
Initiates: Overweight
Price Target: $185
Current: $158.36
Upside: +16.82%
Hologic
May 2, 2023
Maintains: Equal-Weight
Price Target: $80 → $85
Current: $76.28
Upside: +11.43%
IQVIA Holdings
May 1, 2023
Maintains: Equal-Weight
Price Target: $235 → $220
Current: $232.94
Upside: -5.56%
ICON PLC
May 1, 2023
Maintains: Equal-Weight
Price Target: $245 → $220
Current: $301.61
Upside: -27.06%
Avantor
Feb 8, 2023
Maintains: Overweight
Price Target: $25 → $28
Current: $24.42
Upside: +14.66%
Quest Diagnostics
Feb 3, 2023
Maintains: Equal-Weight
Price Target: $135 → $140
Current: $137.55
Upside: +1.78%
Bio-Techne
Jan 10, 2023
Upgrades: Equal-Weight
Price Target: $90
Current: $73.46
Upside: +22.52%